Presentations & Publications

Presentation

2017 Investor Analyst Day

June 12, 2017

Publication

Immunotherapy of Breast Cancer: World Congress on Breast Cancer

August 2015

Presentation

Combination Lm-LLO Immunotherapy plus Radiation Delays Tumor Progression and Prolongs Survival in Osteosarcoma

ACVIM, June 8, 2015

Presentation

AACR 2015 Reception Presentation with Late Breaking Poster

AACR, April 19, 2015

Publication

Lm-LLO Immunotherapies Targeting Multiple Antigens and Their Impact on Different Mechanisms in the Tumor Microenvironment

SITC, November 10, 2014

Presentation

A recombinant HER2/Neu expressing Listeria monocytogenes (Lm9LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma

SITC, November 10, 2014

Publication

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human

Published in Cancer Gene Therapy, January 2011

Publication

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.

Published in Cancer Gene Therapy, January 2011

Publication

High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action

Published in Cancer Research, July 7, 2009

Publication

An Anti-VEGFR2/Flk-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu Positive Breast Tumors in a Mouse Model

Published in the Journal of Immunology, May 1, 2009

Publication

An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.

Published in the Journal of Immunology, May 1, 2009

Publication

A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors

Published in Clinical Cancer Research, February 1, 2009